#USA #New York #Healthcare Awards #Medical Innovation #Prix Galien

Galien Foundation Celebrates 20 Years of Innovation

The Galien Foundation marked the significant 20th anniversary of its Prix Galien USA Awards at a gala event held at the American Museum of Natural History in New York City on October 30, 2026. This ceremony brought together eminent figures from the biomedical industry and academia to honor exemplary achievements in medical innovation and patient care. The 2026 awards recognized outstanding contributions to healthcare by selecting winners in eight distinguished categories ranging from Best Biotechnology Product to the newly introduced Prix Galien Patient First Award.

A Distinguished Panel of Judges

The winners were chosen by the Prix Galien USA Committee, which included 25 committee members, 11 subcommittee members, and 15 advisory board members, three of whom are Nobel Laureates. This meticulous selection process underscores the award's prestige and its role in encouraging advancements in life sciences. "The Prix Galien Awards celebrate the visionaries who are redefining healthcare and reshaping how diseases are diagnosed, treated, and prevented," stated Kenneth Frazier, Chair of the Prix Galien Committee and former Merck CEO.

Highlighting the 2026 Award Winners

This year's award winners exhibited remarkable innovation across various fields:

• - Best Biotechnology Product: Denali Therapeutics Inc. for AVLAYAH™ (tividenofusp alfa-eknm)
• - Best Pharmaceutical Product: Novartis for PLUVICTO®
• - Best Product for Rare/Orphan Diseases: Syndax Pharmaceuticals for REVUFORJ®
• - Best Medical Technology: Guardant Health for Shield™
• - Best Digital Health Solution: AEYE Health for AEYE-DS (AEYE Diagnostic Screening)
• - Incubators, Accelerators and Equity: PureTech Health
• - Prix Galien EcoHealth: California Resources Corporation / Carbon TerraVault
• - Best Startup: Science Corporation (Medical Technology/Digital Health) and Strand Therapeutics (Biotechnology)

In addition to these categories, the inaugural Prix Galien Patient First Award highlighted initiatives focused on improving patient experiences. Bristol Myers Squibb’s Patient Expert Engagement Resource (PEER) Program emerged as a standout private sector-led initiative, while the Cure HHT’s “Nothing About HHT Without Us” program captured the patient-led initiative award.

A Special Honor for Global Health Equity

John Kerry, former U.S. Secretary of State, received the Roy Vagelos Pro Bono Humanum Award for his lifelong commitment to global health, human rights, and environmental sustainability. His efforts in advocating for HIV/AIDS relief and public health initiatives have significantly impacted global health policies. "As we celebrate two decades of honoring excellence in healthcare in the U.S., we also recognize the achievements of our international recipients and Patient First Award honorees, highlighting their relentless dedication to scientific innovation and patient care," remarked Bruno Cohen, Chairman of The Galien Foundation.

The Legacy of Prix Galien

The Prix Galien, which began in 1970 by Roland Mehl, honors exceptional innovations in medical science and is often referred to as the Nobel Prize for the life sciences. With chapters in 16 countries, the Prix Galien awards have gained global recognition as a prestigious accolade in the healthcare industry.

The anniversary celebration served not only as a recognition of past accomplishments but also as a motivation for future advancements in medical technology and patient care. The Galien Foundation remains committed to fostering innovation and ensuring impactful contributions to the world of healthcare for years to come.

The event was not only a tribute to current achievements but also a beacon of hope for ongoing developments that will continue to transform the landscape of healthcare.

For more information on the Prix Galien Foundation and its initiatives, visit galienfoundation.org.